BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 17850324)

  • 1. Generic products of antiepileptic drugs (AEDs): is it an issue?
    Bialer M
    Epilepsia; 2007 Oct; 48(10):1825-32. PubMed ID: 17850324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M; Midha KK
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A; Herranz JL
    Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
    Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
    Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing generic antiepileptic drugs: Issues and concerns for nurse practitioners.
    Barrett MW
    J Am Acad Nurse Pract; 2010 Jun; 22(6):300-4. PubMed ID: 20536627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F; Duh MS; Gosselin A; Paradis PE
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirements for generic antiepileptic medicines: a clinical perspective.
    Trinka E; Krämer G; Graf M
    J Neurol; 2011 Dec; 258(12):2128-32. PubMed ID: 21667222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic equivalency of generic antiepileptic drugs: results of a survey.
    Wilner AN
    Epilepsy Behav; 2004 Dec; 5(6):995-8. PubMed ID: 15582850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy.
    Haskins LS; Tomaszewski KJ; Crawford P
    Epilepsy Behav; 2005 Aug; 7(1):98-105. PubMed ID: 15961350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
    Anderson GD
    Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perception of generic antiepileptic drugs in the Midwestern United States.
    Papsdorf TB; Ablah E; Ram S; Sadler T; Liow K
    Epilepsy Behav; 2009 Jan; 14(1):150-3. PubMed ID: 18845274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic products of antiepileptic drugs: a perspective on bioequivalence, bioavailability, and formulation switches using Monte Carlo simulations.
    Karalis V; Macheras P; Bialer M
    CNS Drugs; 2014 Jan; 28(1):69-77. PubMed ID: 24092569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of generic medication in epilepsy: a review of potential issues and challenges.
    Van Paesschen W; Hauman H; Lagae L
    Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic substitution of anti-epileptic drugs. A needed battle?
    Al-Baradie RS
    Neurosciences (Riyadh); 2008 Jul; 13(3):211-6. PubMed ID: 21063327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden associated with the use of generic antiepileptic drugs in the United States.
    Helmers SL; Paradis PE; Manjunath R; Duh MS; Lafeuille MH; Latrémouille-Viau D; Lefebvre P; Labiner DM
    Epilepsy Behav; 2010 Aug; 18(4):437-44. PubMed ID: 20580619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.